Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva, Miklós Egyed, Viktor Rossiev, Petr Ďulíček, Árpád Illés, Halyna Pylypenko, Lylia Sivcheva, Jiřı́ Mayer, Vera Yablokova, Kurt Krejcy, Barbara Grohmann-Izay, Hans Carl Hasselbalch, Róbert Královics, Jean‐Jacques Kiladjian, F. Samuel Bauer, Nicoleta P. Berbec, Carlos Besses Raebel, Zita Borbényi, Horia Bumbea, Veronika Buxhofer‐Ausch, Małgorzata Całbecka, Emilie Cayssials-Caylus, Mario Cazzola, O Cerná, Andrei Cucuianu, Delia Dima, Ernst Forjan, Emanuil Gheorghita, Richard Greil, Antónia Hatalova, M Hrubisko, János Jakucs, Polina Kaplan, Sergiy Klymenko, Steffen Koschmieder, Mihaela Lazaroiu, Tamila Lysa, Zvenyslava Masliak, Tamás Masszi, Georgi Mihaylov, Alexander Myasnikov, Uwe Platzbecker, Mathieu Puyade, Jérôme Rey, Lydia Roy, Jiřı́ Schwarz, Aleksander B. Skotnicki, I. Ya. Sokolova, Maria Soroka‐Wojtaszko, Jolanta Starzak-Gwóźdź, Vera Stoeva, Jose Miguel Torregrosa‐Diaz, Anna Vallova, Elena Volodicheva, Krzysztof Warzocha, Ella Willenbacher, Dominik Wolf‎